Združene države Amerike - angleščina - NLM (National Library of Medicine)

allure labs, inc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - acne treatment cream uses: treats acne, dries up acne, helps prevent new acne do not use: on a broken skin if pregnant or lactating stop use and ask a doctor if too much irritation or sensitivity developes or increases

Združene države Amerike - angleščina - NLM (National Library of Medicine)

izeen pharma, inc. - zinc acetate (unii: fm5526k07a) (zinc cation - unii:13s1s8sf37), zinc gluconate (unii: u6wsn5sq1z) (zinc cation - unii:13s1s8sf37) - reduces duration and severity of the common cold -  may reduce duration of the common cold -  may reduce the severity of cold symptoms stuffy nose sneezing coughing nasal congestion - stuffy nose - sneezing - coughing - nasal congestion

Saudova Arabija - angleščina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

alkan pharma, egypt - cream - triglycerid, aluminium silicate, magnissium silicate, carbonate

Saudova Arabija - angleščina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

kendy ltd, bulgaria - capsule - 220 mg - vitamin c, vitamin e, vitamin b1, vitamin b2, vitamin b6, vitamin h, vitamin b12, vitamin b9, vitamin pp, vitamin b5, vitamin d3, vitamin k1, pro vitamin a, potassium, chloride, iron, manganese, copper, zinc, selenium, calcium, magnisium, phosphorus,inoli

Saudova Arabija - angleščina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

kendy ltd, bulgaria - capsule - 200.300.540..250 mg - vitamin c, vitamin e, vitamin b1, vitamin b2, vitamin b6, vitamin h, vitamin b12, vitamin b9, vitamin pp, vitamin b5, vitamin d3, vitamin k1, pro vitamin a, potassium, chloride, iron, manganese, copper, zinc, selenium, calcium, magnisium, phosphorus,inoli

Združene države Amerike - angleščina - NLM (National Library of Medicine)

wg critical care, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 1 g in 100 ml - magnesium sulfate in 5% dextrose injection, usp is indicated for: magnesium sulfate in 5% dextrose injection is contraindicated in patients: risk summary magnesium sulfate in 5% dextrose injection is indicated in pregnant women for the prevention of eclampsia in women with preeclampsia and the treatment of seizures and prevention of recurrent seizures in women with eclampsia. fetal, neonatal, and maternal risks are discussed throughout the labeling. clinical considerations labor or delivery: magnesium sulfate in 5% dextrose injection is not approved for the treatment of pre-term labor. administration of magnesium sulfate in 5% dextrose injection to pregnant women longer than 5 to 7 days may lead to hypocalcemia and bone abnormalities in the developing fetus, including skeletal demineralization and osteopenia [see warnings and precautions (5.1)] . the use of intravenous magnesium in pregnant women increases human milk magnesium concentrations only slightly and oral absorption of magnesium by the infant is poor. the effect of intravenous magnesium on milk production is unknown. the developmental and health benefits to the neonate of breastfeeding should be considered along with the mother's clinical need for magnesium sulfate in 5% dextrose injection and any potential adverse effects on the breastfed infant from magnesium sulfate in 5% dextrose injection or from the underlying maternal condition. the safety and effectiveness of magnesium sulfate in 5% dextrose injection have been established for the prevention of eclampsia in adolescents with preeclampsia and the treatment of seizures and prevention of recurrent seizures in adolescents with eclampsia. dosing recommendation in pregnant adolescent patients are the same as for pregnant adult patients [see dosage and administration (2.2)] . magnesium is excreted solely by the kidneys. patients with severe renal impairment (urine output less than 100 ml per 4 hours) are at greater risk for increased magnesium concentrations that may lead to magnesium toxicity [see warnings and precautions (5.2) and clinical pharmacology (12.3)] . in patients with severe renal impairment, dosage reduction is recommended and the maximum recommended dosage is lower than patients with normal renal function [see dosage and administration (2.3)] .